Robert S. Breuil

Robert S. Breuil (finance chief) discloses dealings in 2 companies, chiefly CalciMedica, Inc. and Corium International, Inc. Between 21 November 2014 and 23 March 2023, the trades on record add up to 29 filings.

Both buying and selling appear: 2 purchases worth €20k, against 3 sales worth €32k. The net balance comes to €12k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 9 share grants and 13 option exercises.

The record was last updated on 27 March 2023 with a share grant (€64k) in CalciMedica, Inc. The last insider purchase was made public on 24 November 2014, 4,351 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.